fda tirzepatide update today BREAKING NEWS!!! A weight loss drug more effective than Semaglutide has been approved by the today. (Zepbound for weight loss and Mounjaro for diabetes) showed a 15-20.9% weight change in FDA approves Zepbound (tirzepatide) as

It can cause symptoms such as anemia, abdominal pain, weight loss, constipation, diarrhea and the presence of blood or mucus in the stool

Sam Altman has officially been reinstated atop OpenAI as CEO 'I have never been more excited about the future,' says Altman Sam Altman confirmed on Wednesday that he was returning to the helm at OpenAI as CEO, nearly two weeks after he was ousted from the company he co-founded

Abstract Neurodegenerative diseases represent a major global cause of mortality and disability

Manfredi-Lozano M, et al

Provider oversight ensures you're balancing metabolic benefits with quality-of-life concerns and can pivot to oral options, lower doses, or alternative formulations if needed